<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>SEHS: FusionDrive:Driving targeted immune responses (2026) - Project Promotion</title>
        <link>https://video.igem.org/videos/watch/fb5fd7ba-3ab9-4436-abc4-d4a0f0c90798</link>
        <description>Title: FusionDrive:Driving targeted immune responses Description: Cancer remains one of the greatest threats to human health, and current treatments often cause severe side effects. Our project focuses on developing a novel immunotherapy strategy using synthetic biology. We designed a TIGIT-targeting monoclonal antibody to block inhibitory signals in exhausted T cells and restore their anti-tumor activity. Furthermore, we constructed an antibody-cytokine fusion protein to enhance T-cell activation and proliferation. Through engineering the immune system, we hope to provide a more precise and effective approach for cancer treatment. Official Page</description>
        <lastBuildDate>Sat, 29 Aug 2026 17:16:44 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>PeerTube - https://video.igem.org</generator>
        <image>
            <title>SEHS: FusionDrive:Driving targeted immune responses (2026) - Project Promotion</title>
            <url>https://video.igem.org/client/assets/images/icons/icon-1500x1500.png</url>
            <link>https://video.igem.org/videos/watch/fb5fd7ba-3ab9-4436-abc4-d4a0f0c90798</link>
        </image>
        <copyright>All rights reserved, unless otherwise specified in the terms specified at https://video.igem.org/about and potential licenses granted by each content's rightholder.</copyright>
        <atom:link href="https://video.igem.org/feeds/video-comments.xml?videoId=fb5fd7ba-3ab9-4436-abc4-d4a0f0c90798" rel="self" type="application/rss+xml"/>
    </channel>
</rss>